Disease-modifying drugs for multiple sclerosis and subsequent health service use.
Huah Shin NgFeng ZhuElaine KingwellYinshan ZhaoShenzhen YaoOkechukwu EkumaLawrence W SvensonCharity EvansJohn D FiskKathryn C FitzgeraldHelen TremlettPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Findings provide real-world evidence of a beneficial relationship between DMD exposure and hospitalizations.